Extramedullary progression of multiple myeloma following GM-CSF treatment--grounds for caution?
Celsing
F
F
Hast
R
R
Stenke
L
L
Hansson
H
H
Pisa
P
P
D016207:Cytokines / Q000097:blood; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D011241:Prednisone / Q000627:therapeutic use
D016207:Cytokines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008558:Melphalan; D011241:Prednisone